Inclisiran - Alnylam Pharmaceuticals/Novartis
At a glance
- Drug Originator Alnylam Pharmaceuticals
- Drug Licenced by Novartis
- Drug Class Amides; Amino sugars; Antihyperlipidaemics; Cardiovascular therapies; Drug conjugates; Small interfering RNA; Vascular disorder therapies
- Mechanism of Action PCSK9 protein expression inhibitors; RNA interference
- USA Patent Applicants NOVARTIS
- USA Patents 32
- NDAs 1
- International Patents 167
Table of Contents
Disclaimer